Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 15Neoplasms 12Carcinoma, Hepatocellular 12Uterine Cervical Neoplasms 10Esophageal Neoplasms 10Nasopharyngeal Carcinoma 8Carcinoma, Non-Small-Cell Lung 8Ovarian Neoplasms 6Carcinoma, Ovarian Epithelial 6Melanoma 5Lung Neoplasms 5Colorectal Neoplasms 5Thyroid Cancer, Papillary 4Stomach Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Motor Activity 4Hematologic Neoplasms 4Fallopian Tube Neoplasms 4Esophageal Squamous Cell Carcinoma 4Endometrial Neoplasms 4Colonic Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Pain 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Uveal Melanoma 2Thyroid Neoplasms 2Skin Neoplasms 2

Interventions

sintilimab 1Oxaliplatin 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER_GOV × Colorectal Cancer Liver Metastasis × Clear all
NCT06788171 2025-01-23

PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM

Fujian Cancer Hospital

Phase 2 Not yet recruiting
35 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡